CNECC(601611)

Search documents
中国核建:中国核建第四届监事会第十二次会议决议公告
2023-08-15 11:06
中国核工业建设股份有限公司 第四届监事会第十二次会议决议的公告 本公司监事会及全体监事保证本公告内容不存在任何虚假记载、误导性陈述或 者重大遗漏,并对其内容的真实性、准确性和完整性承担法律责任。 中国核工业建设股份有限公司(以下简称"公司")第四届监事会第十二次 会议于 2023 年 8 月 15 日以通讯形式召开。会议通知于 2023 年 8 月 8 日以电子邮 件形式送达各位监事。本次会议应参会监事 3 人,实到监事 3 人。本次会议的召 开符合《中华人民共和国公司法》和《中国核工业建设股份有限公司章程》的有 关规定。 | 证券代码:601611 | 证券简称:中国核建 公告编号:2023-069 | | --- | --- | | 转债代码:113024 | 转债简称:核建转债 | 1.通过了《关于限制性股票激励计划符合第二个解锁期解除限售条件激励对 象的议案》 同意票数 3 票,占表决票数的 100%;反对票数 0 票,占表决票数的 0%;弃 权票数 0 票,占表决票数的 0%。 特此公告。 中国核工业建设股份有限公司监事会 2023 年 8 月 16 日 1 本次会议由公司监事会主席王正勇先生主持, ...
中国核建:中国核建关于经营情况简报的公告
2023-08-14 10:16
| 证券代码:601611 | 证券简称:中国核建 公告编号:2023-065 | | --- | --- | | 转债代码:113024 | 转债简称:核建转债 | 中国核工业建设股份有限公司 关于经营情况简报的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏,并对其内容的真实性、准确性和完整性承担法律责任。 现将公司 2023 年 7 月主要经营情况公布如下,供各位投资者参 考: 一、截至 2023 年 7 月,公司累计新签合同 701.81 亿元,比上年 同期增长-6.79%。 二、截至 2023 年 7 月,公司累计实现营业收入 609.21 亿元,比 上年同期增长 2.17%。 以上数据未经审计,由于客户情况变化等各种因素,未来营业收 入与签约额并不完全一致,特别提醒投资者注意。 中国核工业建设股份有限公司董事会 2023 年 8 月 15 日 ...
中国核建:中国核建股权激励限制性股票回购注销实施公告
2023-08-14 10:14
| 证券代码:601611 | 证券简称:中国核建 公告编号:2023-066 | | --- | --- | | 转债代码:113024 | 转债简称:核建转债 | 中国核工业建设股份有限公司 股权激励限制性股票回购注销实施公告 公司董事会及全体董事保证公告内容不存在任何虚假记载、误导性陈述或者重 大遗漏,并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示: | 回购股份数量 | 注销股份数量 | 注销日期 | | | | | --- | --- | --- | --- | --- | --- | | 600,402 | 600,402 | 8 | 月 | 17 | 日 | 根据《限制性股票激励计划(草案修订稿)》第三十七条有关规定,14 名激 励对象因工作原因不满足激励条件,其获授的限制性股票中尚未解除限售的由公 司回购,并按照《公司法》的规定进行处理。 一、本次限制性股票回购注销的决策与信息披露 2023 年 6 月 6 日,公司召开第四届董事会第十一次会议和第四届监事会第 十次会议,审议通过了《关于回购部分限制性股票的议案》《关于注销部分限制 性股票并减少注册资本的议案》,同意按照《中国核 ...
中国核建:中国核建关于可转换公司债券转股价格调整的公告
2023-08-14 10:12
中国核工业建设股份有限公司(以下简称"中国核建"或"公司")于 2019 年 4 月 8 日发行了 299,625 万元可转换公司债券(转债简称:核建转债,转债代 码:113024),根据《中国核工业建设股份有限公司公开发行可转换公司债券募 集说明书》发行条款以及中国证券监督管理委员会(以下简称"中国证监会")关 于可转换公司债券发行的有关规定,"核建转债"在本次发行之后,当公司发生 派送股票股利、转增股本、增发新股或配股、派送现金股利等情况(不包括因本 次发行的可转债转股而增加的股本)使公司股份发生变化时,将按下述公式进行 转股价格的调整(保留小数点后两位,最后一位四舍五入): 派送股票股利或转增股本:P1=P0/(1+n); 增发新股或配股:P1=(P0+A×k)/(1+k); | 证券代码:601611 | 股票简称:中国核建 | 公告编号:2023-067 | | --- | --- | --- | | 转债代码:113024 | 转债简称:核建转债 | | 中国核工业建设股份有限公司 关于可转换公司债券转股价格调整的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗 ...
中国核建:中国核建关于经营情况简报的公告
2023-07-14 09:37
| 证券代码:601611 | 证券简称:中国核建 公告编号:2023-057 | | --- | --- | | 转债代码:113024 | 转债简称:核建转债 | 中国核工业建设股份有限公司 关于经营情况简报的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏,并对其内容的真实性、准确性和完整性承担法律责任。 现将公司 2023 年 6 月主要经营情况公布如下,供各位投资者参 考: 一、截至 2023 年 6 月,公司累计新签合同 654.65 亿元,比上年 同期增长-6.62%。 二、截至 2023 年 6 月,公司累计实现营业收入 543.11 亿元,比 上年同期增长 4.11%。 以上数据未经审计,由于客户情况变化等各种因素,未来营业收 入与签约额并不完全一致,特别提醒投资者注意。 中国核工业建设股份有限公司董事会 2023 年 7 月 15 日 ...
中国核建:中国核建关于经营情况简报的公告
2023-06-13 09:16
关于经营情况简报的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏,并对其内容的真实性、准确性和完整性承担法律责任。 现将公司 2023 年 5 月主要经营情况公布如下,供各位投资者参 考: | 证券代码:601611 | 证券简称:中国核建 公告编号:2023-049 | | --- | --- | | 债券代码:113024 | 债券简称:核建转债 | 中国核工业建设股份有限公司 一、截至 2023 年 5 月,公司累计新签合同 545.27 亿元,比上年 同期增长 3.38%。 二、截至 2023 年 5 月,公司累计实现营业收入 433.72 亿元,比 上年同期增长 5.87%。 以上数据未经审计。由于客户情况变化等各种因素,未来营业收 入与签约额并不完全一致,特别提醒投资者注意。 中国核工业建设股份有限公司董事会 2023 年 6 月 14 日 ...
中国核建(601611) - 中国核建投资者关系活动记录表
2023-05-24 09:58
证券代码:601611 证券简称:中国核建 中国核工业建设股份有限公司投资者关系活动记录表 | --- | --- | --- | --- | |--------------------|---------------|-------------------|-----------| | | □特定对象调研 | □分析师会议 | 媒体采访 | | 投资者关系活动类别 | √业绩说明会 | □新闻发布会 | □路演活动 | | | □现场参观 | □其他(电话会议) | | 时间 2023年5月23日 14:00-15:30 会议方式 现场会议:中国核电科技馆(浙江省海盐县核电大道888号) 董事长:陈宝智 总会计师:丁淑英 公司接待人员姓名 副总经理、董事会秘书:高金柱 证券事务代表:张云普 工程管理部总经理:廖钟鸣 中信建投、信达证券、国泰君安、产业基金、华泰证券、东北证券、 国盛证券、中泰证券、广发证券、天风证券、长江养老、中科沃土、 融通基金、国海资管、汇添富基金、嘉实基金、中邮证券、禾永投 参与投资者 资、中船财务、浙商证券、宏道投资、惠民基金、鹏扬基金等机构 投资者和分析师 | --- | |--- ...
中国核建:中国核建关于经营情况简报的公告
2023-05-15 09:52
一、截至 2023 年 4 月,公司累计新签合同 495.47 亿元,比上年 同期增长 25.46%。 二、截至 2023 年 4 月,公司累计实现营业收入 359.05 亿元,比 上年同期增长 8.48%。 以上数据未经审计。由于客户情况变化等各种因素,未来营业收 入与签约额并不完全一致,特别提醒投资者注意。 中国核工业建设股份有限公司董事会 | 证券代码:601611 | 证券简称:中国核建 公告编号:2023-041 | | --- | --- | | 债券代码:113024 | 债券简称:核建转债 | 中国核工业建设股份有限公司 关于经营情况简报的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏,并对其内容的真实性、准确性和完整性承担法律责任。 现将公司 2023 年 4 月主要经营情况公布如下,供各位投资者参 考: 2023 年 5 月 16 日 ...
中国核建(601611) - 2023 Q1 - 季度财报
2023-04-28 16:00
Financial Performance - The company's operating revenue for Q1 2023 was CNY 28,928,590,332.73, representing a year-on-year increase of 10.09%[4] - The net profit attributable to shareholders was CNY 508,220,568.71, reflecting a growth of 20.15% compared to the same period last year[4] - The net profit attributable to shareholders after deducting non-recurring gains and losses was CNY 499,755,836.31, an increase of 20.60% year-on-year[4] - The basic earnings per share for the period was CNY 0.17, up by 21.43% from the previous year[5] - The diluted earnings per share was CNY 0.16, showing a growth of 23.08% year-on-year[5] - The total comprehensive income for the first quarter of 2023 was CNY 699,666,840.27, an increase from CNY 592,717,567.92 in the same period of 2022, representing a growth of approximately 18.0%[28] - Basic earnings per share for Q1 2023 was CNY 0.17, up from CNY 0.14 in Q1 2022, reflecting a growth of about 21.4%[28] Cash Flow and Liquidity - The net cash flow from operating activities was negative at CNY -11,667,784,488.30, indicating a significant cash outflow[4] - Cash inflow from operating activities totaled CNY 17,738,742,727.31, down from CNY 20,415,829,030.80 in the previous year, indicating a decrease of approximately 13.1%[31] - Net cash flow from operating activities was negative at CNY -11,667,784,488.30, compared to CNY -11,306,457,057.96 in Q1 2022, showing a slight increase in cash outflow[31] - Cash inflow from investment activities was CNY 733,028,328.81, a marginal increase from CNY 714,750,419.69 in the same quarter of 2022[31] - Net cash flow from financing activities was CNY 8,659,677,204.35, down from CNY 9,025,306,261.34 in Q1 2022, reflecting a decrease of about 4.0%[32] - The ending balance of cash and cash equivalents was CNY 13,532,493,114.18, compared to CNY 9,966,543,715.83 at the end of Q1 2022, indicating an increase of approximately 35.7%[32] - The company reported a decrease in cash received from sales of goods and services, totaling CNY 16,524,671,119.55, down from CNY 18,794,760,913.19 in Q1 2022, a decline of about 12.1%[29] - The company received tax refunds amounting to CNY 6,287,431.58, an increase from CNY 4,052,176.83 in the previous year, representing a growth of approximately 55.2%[31] - The company’s total cash outflow from operating activities was CNY 29,406,527,215.61, down from CNY 31,722,286,088.76 in Q1 2022, indicating a decrease of about 7.3%[31] Assets and Liabilities - Total assets at the end of the reporting period amounted to CNY 205,201,488,725.29, a 3.97% increase from the end of the previous year[5] - The total liabilities increased to CNY 205.20 billion from CNY 197.37 billion year-over-year[22] - The company's total liabilities increased to CNY 169,192,427,873.89 in Q1 2023, compared to CNY 162,287,271,972.80 in Q1 2022, marking a rise of 4.0%[24] - The total current assets as of March 31, 2023, amounted to CNY 135.63 billion, an increase from CNY 127.16 billion in the previous year[20] - The total inventory as of March 31, 2023, was CNY 12.97 billion, up from CNY 11.78 billion year-over-year[22] - The company has a long-term equity investment valued at CNY 2.96 billion, slightly increasing from CNY 2.94 billion[22] - The total amount of accounts payable was CNY 45,182,277,446.02 in Q1 2023, slightly down from CNY 45,257,875,126.84 in Q1 2022[23] - The company reported a 244.20% increase in long-term payables due to PPP project asset securitization financing[10] Shareholder Information - The number of ordinary shareholders at the end of the reporting period was 91,658[11] - The company reported a total of 1,621,620,000 shares held by China National Nuclear Corporation, making it the largest shareholder[17] Research and Development - Research and development expenses for Q1 2023 were CNY 304,518,951.15, an increase of 16.7% from CNY 260,883,138.12 in Q1 2022[25] Future Outlook - Future outlook includes continued focus on market expansion and new product development, although specific figures were not disclosed in the provided data[25]
中国核建(601611) - 2022 Q4 - 年度财报
2023-04-28 16:00
Financial Performance - The company reported a cumulative distributable profit of RMB 592,013,726.10 as of December 31, 2022, with a cash dividend distribution plan of RMB 0.79 per 10 shares, totaling RMB 238,557,439.81[3]. - The company's operating revenue for 2022 was CNY 99.14 billion, an increase of 18.42% compared to CNY 83.72 billion in 2021[14]. - Net profit attributable to shareholders for 2022 reached CNY 1.75 billion, reflecting a growth of 14.48% from CNY 1.53 billion in the previous year[14]. - The net profit after deducting non-recurring gains and losses was CNY 1.62 billion, up 21.05% from CNY 1.34 billion in 2021[14]. - The company's total assets as of the end of 2022 were CNY 197.37 billion, a 14.92% increase from CNY 171.74 billion at the end of 2021[14]. - The weighted average return on equity for 2022 was 10.85%, an increase of 0.08 percentage points from 10.77% in 2021[16]. - Basic earnings per share for 2022 were CNY 0.56, up 14.29% from CNY 0.49 in 2021[15]. - The net cash flow from operating activities for 2022 was negative CNY 4.40 billion, compared to positive CNY 2.41 billion in 2021[14]. - The company achieved operating revenue of 99.138 billion RMB, a year-on-year increase of 18.42%[24]. - The net profit attributable to shareholders reached 1.755 billion RMB, growing by 14.48% year-on-year[24]. Audit and Compliance - The company has received a standard unqualified audit report from Xinyong Zhonghe Accounting Firm[2]. - The board of directors and supervisory board members have all attended the board meeting, ensuring the accuracy and completeness of the annual report[2]. - There are no non-operating fund occupations by controlling shareholders or related parties reported[3]. - The company has not violated any decision-making procedures regarding external guarantees[3]. - The company has not faced any penalties from securities regulatory authorities in the past three years[92]. - The company has confirmed that there are no non-operating fund occupations by controlling shareholders or related parties[141]. - The company has not encountered any violations regarding guarantees during the reporting period[141]. - The company has not reported any significant accounting errors that would require correction[144]. Risk Management - The company has outlined potential risks and countermeasures in the management discussion and analysis section of the report[3]. - The company implemented a comprehensive risk management framework, strengthening legal, internal control, and compliance systems[27]. - The company is focused on risk management, particularly in cash flow and project operation risks, implementing measures to improve cash flow efficiency and project recovery rates[76]. Corporate Governance - The board of directors has been restructured, with 9 members, including a majority of external directors and one-third independent directors, enhancing governance and decision-making processes[78]. - The company has established a comprehensive governance framework, focusing on value creation and investor protection, and has implemented 54 measures to improve corporate quality[78]. - The company is focused on enhancing its governance structure through the election of independent directors and the establishment of various committees[93]. - The company has implemented a performance assessment responsibility letter for its management team, which was approved in a board meeting[92]. Research and Development - R&D investment has been continuously increasing, with over 500 patent applications filed during the year[26]. - The total R&D expenditure for the period was CNY 1,635,026,982.91, accounting for 1.65% of the operating revenue[47]. - The number of R&D personnel is 7,168, representing 16.53% of the total workforce[48]. Market and Industry Position - The company is currently managing 22 nuclear power units under construction, with 28 major milestone completions[24]. - The company is the only global entity to have continuously engaged in nuclear power construction for 38 years, showcasing its leading position in the industry[33]. - The company aims to enhance its market competitiveness by integrating nuclear safety management practices into civil projects[32]. - The renewable energy sector saw a significant increase, with wind and solar power accounting for 76% of new installed capacity in 2022[30]. - The company is actively expanding its market share in new infrastructure and renewable energy sectors, aligning with national strategic priorities[32]. Employee and Compensation - The total remuneration for current directors (excluding independent directors), supervisors, and senior management in the reporting period amounted to CNY 10.7892 million, while independent directors received CNY 0.3 million[90]. - The company maintains a performance-based compensation system that favors grassroots and value-contributing employees[105]. - The company has a stock incentive plan approved by the State-owned Assets Supervision and Administration Commission, aimed at enhancing employee motivation and retention[110]. - The total number of professional technical personnel is 21,789, indicating a strong focus on skilled workforce development[104]. Environmental and Social Responsibility - The company invested 19,827,000 RMB in environmental protection during the reporting period[120]. - The company received a total of 110,290 RMB in fines for environmental issues, with two penalties issued[121]. - The company contributed 3,294,200 RMB to public welfare projects, primarily for disaster relief and prevention efforts[126]. - A total of 3,021,000 RMB was invested in poverty alleviation and rural revitalization projects, benefiting 6,603 people[127]. Financial Management - The company reported a significant increase in financing activities, with net cash flow from financing activities reaching CNY 13.04 billion, a 67.61% increase from the previous year[37]. - The company has a daily average deposit balance of RMB 85.46 billion with China Nuclear Finance Co., with a loan balance of RMB 88.75 billion[158]. - The company has a loan limit of RMB 242.2 billion with China Nuclear Finance Co., with an interest rate range of 2.7%-4.35%[162]. - The company has not faced any overdue bonds during the reporting period, indicating strong financial management[197]. Future Outlook - The company anticipates a GDP growth of approximately 5% in 2023, driven by a recovery in consumption and sustained investment[69]. - In 2023, the company plans to sign new contracts worth 157.2 billion RMB and expects revenue of 109.3 billion RMB, focusing on enhancing its competitive edge in nuclear power engineering and expanding into industrial and civil markets[75]. - The company is committed to enhancing its core competitiveness in nuclear power engineering and optimizing its business structure to increase the proportion of high-quality projects[75].